株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の灌流画像市場:2024年までの予測

Global Perfusion Imaging Market Research Report Forecast to 2024

発行 Market Research Future 商品コード 913714
出版日 ページ情報 英文 98 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
世界の灌流画像市場:2024年までの予測 Global Perfusion Imaging Market Research Report Forecast to 2024
出版日: 2019年09月30日 ページ情報: 英文 98 Pages
概要

世界の灌流画像市場は、2024年までの間に6.34%びCAGRで成長する見通しで、2024年には77億4,557万米ドルに達すると予測されています。

当レポートは世界の灌流画像について調査しており、市場機会、成長および阻害要因、モダリティ・用品・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の紹介

第3章 調査方法

第4章 市場力学

  • 概要
  • 成長要因
  • 阻害要因
  • 市場機会
  • マクロ経済指標

第5章 市場要因分析

  • バリューチェーン分析
    • 研究開発・設計
    • 製造業
    • 包装・組み立て
    • 流通・販売
    • 販売後レビュー
  • ポーターのファイブフォース分析
    • サプライヤーの交渉力
    • バイヤーの交渉力
    • 新規参入の脅威
    • 代替品の脅威
    • 業界内の競争

第6章 市場分析:モダリティ別

  • 概要
  • CT
  • MRI
  • 核医学

第7章 市場分析:用途別

  • 概要
  • 心筋灌流画像
  • 換気灌流画像
  • 機能的脳画像

第8章 市場分析:地域別

  • 概要
  • 南北アメリカ
    • 北米
    • ラテンアメリカ
  • 欧州
    • 西欧
    • 東欧
  • アジア太平洋地域
  • 中東・アフリカ
    • 中東
    • アフリカ

第9章 競合情勢

  • 概要
  • 競合ベンチマーク
  • 開発件数における主なプレーヤー
  • 主要開発分析
    • パートナーシップ/戦略的合意
    • 取得
    • 製品の承認
    • 拡張

第10章 企業プロファイル

  • General Electric Company
  • Siemens
  • Medtronic
  • キヤノンメディカルシステムズ株式会社
  • Bracco Diagnostic, Inc.
  • Koninklijke Philips NV
  • Neusoft Corporation
  • Lantheus Medical Imaging, Inc.
  • Shimadzu Corporation
  • Aetna
  • Perimed
  • Advantis Medical Imaging

第11章 付録

  • 参照資料
  • 関連レポート
図表

List of Tables

  • TABLE 1 PRIMARY INTERVIEWS
  • TABLE 2 GLOBAL PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 3 GLOBAL PERFUSION IMAGING MARKET, FOR COMPUTED TOMOGRAPHY (CT SCAN), BY REGION, 2016-2024 (USD MILLION)
  • TABLE 4 GLOBAL PERFUSION IMAGING MARKET, FOR MAGNETIC RESONANCE IMAGING (MRI SCAN), BY REGION, 2016-2024 (USD MILLION)
  • TABLE 5 GLOBAL PERFUSION IMAGING MARKET, FOR NUCLEAR MEDICINE, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 6 GLOBAL PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 7 GLOBAL PERFUSION IMAGING MARKET, FOR MYOCARDIAL PERFUSION IMAGING, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 8 GLOBAL PERFUSION IMAGING MARKET, FOR VENTILATION PERFUSION IMAGING, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 9 GLOBAL PERFUSION IMAGING MARKET, FOR FUNCTIONAL BRAIN IMAGING, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 10 GLOBAL PERFUSION IMAGING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 11 GLOBAL PERFUSION IMAGING MARKET, BY REGION, 2018 & 2024 (USD MILLION)
  • TABLE 12 AMERICAS: PERFUSION IMAGING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 13 AMERICAS: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 14 AMERICAS: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 15 NORTH AMERICA: PERFUSION IMAGING MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 16 NORTH AMERICA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 17 NORTH AMERICA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 18 US: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 19 US: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 20 CANADA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 21 CANADA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 22 LATIN AMERICA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 23 LATIN AMERICA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION).
  • TABLE 24 EUROPE: PERFUSION IMAGING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 25 EUROPE: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 26 EUROPE: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 27 WESTERN EUROPE: PERFUSION IMAGING MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 28 WESTERN EUROPE: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 29 WESTERN EUROPE: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 30 GERMANY: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 31 GERMANY: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 32 FRANCE: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 33 FRANCE: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 34 UK: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 35 UK: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 36 ITALY: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 37 ITALY: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 38 SPAIN: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 39 SPAIN: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 40 REST OF WESTERN EUROPE: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 41 REST OF WESTERN EUROPE: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 42 EASTERN EUROPE: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 43 EASTERN EUROPE: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: PERFUSION IMAGING MARKET, BY COUNTRY, 2016-2024 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 46 ASIA PACIFIC: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 47 JAPAN: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 48 JAPAN: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 49 CHINA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 50 CHINA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 51 INDIA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 52 INDIA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 53 SOUTH KOREA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 54 SOUTH KOREA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 55 AUSTRALIA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 56 AUSTRALIA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 57 REST OF ASIA PACIFIC: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 58 REST OF ASIA-PACIFIC: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 59 MIDDLE EAST AND AFRICA: PERFUSION IMAGING MARKET, BY REGION, 2016-2024 (USD MILLION)
  • TABLE 60 MIDDLE EAST & AFRICA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 61 MIDDLE EAST & AFRICA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 62 MIDDLE EAST: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 63 MIDDLE EAST: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 64 AFRICA: PERFUSION IMAGING MARKET, BY MODALITY, 2016-2024 (USD MILLION)
  • TABLE 65 AFRICA: PERFUSION IMAGING MARKET, BY APPLICATION, 2016-2024 (USD MILLION)
  • TABLE 66 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PERFUSION IMAGING MARKET
  • TABLE 67 PARTNERSHIP/STRATEGIC AGREEMENT
  • TABLE 68 ACQUISITION
  • TABLE 69 MERGER & ACQUISITION
  • TABLE 70 EXPANSION

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL PERFUSION IMAGING MARKET (2018)
  • FIGURE 3 GLOBAL PERFUSION IMAGING MARKET ANALYSIS BY MODALITY (2018)
  • FIGURE 4 GLOBAL PERFUSION IMAGING MARKET ANALYSIS BY APPLICATION (2018)
  • FIGURE 5 GLOBAL PERFUSION IMAGINGMARKET: MARKET STRUCTURE
  • FIGURE 6 RESEARCH PROCESS
  • FIGURE 7 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 8 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PERFUSION IMAGING MARKET
  • FIGURE 9 DRIVERS: IMPACT ANALYSIS
  • FIGURE 10 RESTRAINTS: IMPACT ANALYSIS
  • FIGURE 11 VALUE CHAIN: GLOBAL PERFUSION IMAGING MARKET
  • FIGURE 12 PORTER'S FIVE FORCES ANALYSIS: GLOBAL PERFUSION IMAGING MARKET
  • FIGURE 13 GLOBAL PERFUSION IMAGING MARKET, BY MODALITY, 2018 (%)
  • FIGURE 14 GLOBAL PERFUSION IMAGING MARKET, BY MODALITY, 2018 & 2014 (USD MILLION)
  • FIGURE 15 GLOBAL PERFUSION IMAGING MARKET, BY APPLICATION, 2018 (%)
  • FIGURE 16 GLOBAL PERFUSION IMAGING MARKET, BY APPLICATION, 2018 & 2014 (USD MILLION)
  • FIGURE 17 GLOBAL PERFUSION IMAGING MARKET, BY REGION, 2018 (%)
  • FIGURE 18 AMERICAS: PERFUSION IMAGING MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 19 NORTH AMERICA: PERFUSION IMAGING MARKET, BY COUNTRY, 2018 (%)
  • FIGURE 20 EUROPE: PERFUSION IMAGING MARKET SHARE, BY REGION, 2018 (%)
  • FIGURE 21 WESTERN EUROPE: PERFUSION IMAGING MARKET, BY COUNTRY, 2018 (%)
  • FIGURE 22 ASIA PACIFIC: PERFUSION IMAGING MARKET, BY COUNTRY, 2018 (%)
  • FIGURE 23 MIDDLE EAST & AFRICA: PERFUSION IMAGING MARKET, BY REGION, 2018 (%)
  • FIGURE 24 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 25 PERFUSION IMAGING MARKET, COMPETITIVE LANDSCAPE (% SHARE)
目次

Perfusion Imaging Market Research Report - Global Forecast till 2024

Global Perfusion Imaging Market: Information by Modality (Computed Tomography (CT Scan), Magnetic Resonance Imaging (MRI) and Nuclear Medicine), Application (Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging and others) and Region - Forecast till 2024

Market Analysis:

To reach USD 7,745.57 Million by the year 2024, the Global Perfusion Imaging Market is anticipated to record a CAGR of 6.34% . Perfusion imaging is a non-invasive imaging test that demonstrates how the blood flows through the organs or tissues. This test is used for the diagnosis of various chronic disorders. Growing prevalence of cardiovascular & neurological diseases, rising geriatric population, and improvements in technology are pushing the growth of the global perfusion imaging market. However, stringent regulatory policies are prone to hinder the market growth. Growing incidence of cardiovascular & neurological diseases and increasing geriatric population are pushing the evolution of the global perfusion imaging market. As, as per the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, in the year 2017, every year about 795,000 people in the US have a hit in which about 610,000 of them are first, or new strokes and185,000 are recurrent strokes. Furthermore, innovations in technology are further stimulating market growth. In the year 2019, January Shimadzu Corporation bought Core Medical Imaging, Inc. to improve its healthcare business in North America. This procurement boosted the company's foothold in the North American market. In March, 2018 GE received approval from Health Canada for Signa Premier, a 3.0T MRI system. This increased the product portfolio of the company. Australia held a share of 11.2% in the Asia-Pacific perfusion imaging market in 2018. Also, the market in the Middle East & Africa is expected to steadily grow owing to the increasing awareness about diseases in the region.

Market Segmentation:

Global Perfusion Imaging Market has been segmented by Modality, by application, and by region. Based on Modality the market is divided into Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI) and Nuclear Medicine. Based on application the market is divided into Myocardial Perfusion Imaging, Ventilation Perfusion Imaging, Functional Brain Imaging, and Others. Based on region the market has been divided into various regions like Americas including US & Canada from North America and Latin America, Europe including Western Europe(Germany, UK, France, Italy, Spain, Rest of Western Europe and Eastern Europe), Asia-Pacific including China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific, and Middle East & Africa.

Regional Analysis:

The Global Perfusion Imaging Market has been distributed into several counties like Americas including US & Canada from North America and Latin America, Europe including Western Europe(Germany, UK, France, Italy, Spain, Rest of Western Europe and Eastern Europe), Asia-Pacific including China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific, and Middle East & Africa. The largest share of the global perfusion imaging market is expected to held by America.This is remaining to the rising rate of cardiovascular diseases, brain tumors, and tumor-related angiogenesis, among others, in the region. Europe showed a considerable amount of evolution in the market due to the rising prevalence of neurological disorders. Asia-Pacific is expected to be the quickest rising region in the global market due to the huge geriatric population and the presence of rapidly developing economies such as China, India, and South Korea.

Key Players:

The major companies functioning in the Global Perfusion Imaging Market are concentrating on firming their global ways by entering into untouched markets. Siemens (Germany), Bracco Diagnostic, Koninklijke Philips NV (Netherlands), lantheus Medical Imaging, Inc. (US), Shimadzu Corporation (Japan), Perimed (US), General Electric Company (US), Medtronic (Ireland), Inc. (Italy), Neusoft Corporation (China), Canon Medical Systems Corporation (Japan), Aetna (US), Advantis Medical Imaging (Netherland), and others are some of the major players in the Global Perfusion Imaging Market .The projected onlookers in the Global EMS and ODM Market are Hospitals Medical devices companies, Research institutes, Contract Research Organizations and Academic institutes.

Table of Contents

1 Executive Summary

  • 1.1 Market Attractiveness Analysis
    • 1.1.1 Global Perfusion Imaging Market, By Modality
    • 1.1.2 Global Perfusion Imaging Market, By Application

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Assumptions & Limitations
    • 2.3.1 Assumptions
    • 2.3.2 Limitations
  • 2.4 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Overview
  • 4.2 Drivers
    • 4.2.1 Growing Prevalence of Cardiovascular and Neurological Diseases
    • 4.2.2 Increasing Geriatric Population
    • 4.2.3 Advancements in Technology
  • 4.3 Restraints
    • 4.3.1 Stringent Regulatory Policies
    • 4.3.2 Lack of Awareness for the Use of Advanced Technologies
  • 4.4 Opportunities
    • 4.4.1 Entering Developing Economies
  • 4.5 Macroeconomic Indicators

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Packaging & Assembly
    • 5.1.4 Distribution & Sales
    • 5.1.5 Post-Sales Review
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry

6 Global Perfusion Imaging Market, By Modality

  • 6.1 Overview
  • 6.2 Computed Tomography (CT Scan)
  • 6.3 Magnetic Resonance Imaging (MRI)
  • 6.4 Nuclear Medicine

7 Global Perfusion Imaging Market, By Application

  • 7.1 Overview
  • 7.2 Myocardial Perfusion Imaging
  • 7.3 Ventilation Perfusion Imaging
  • 7.4 Functional Brain Imaging

8 Global Perfusion Imaging Market, By Region

  • 8.1 Overview
  • 8.2 Americas
    • 8.2.1 North America
      • 8.2.1.1 US
      • 8.2.1.2 Canada
    • 8.2.2 Latin America
  • 8.3 Europe
    • 8.3.1 Western Europe
      • 8.3.1.1 Germany
      • 8.3.1.2 France
      • 8.3.1.3 UK
      • 8.3.1.4 Italy
      • 8.3.1.5 Spain
      • 8.3.1.6 Rest of Western Europe
    • 8.3.2 Eastern Europe
  • 8.4 Asia-Pacific
      • 8.4.1.1 Japan
      • 8.4.1.2 China
      • 8.4.1.3 India
      • 8.4.1.4 South Korea
      • 8.4.1.5 Australia
      • 8.4.1.6 Rest of Asia-Pacific
  • 8.5 Middle East & Africa
    • 8.5.1 Middle East
    • 8.5.2 Africa

9 Competitive Landscape

  • 9.1 Overview
  • 9.2 Competitive Benchmarking
  • 9.3 Leading Players in Terms of Number of Developments in the Perfusion Imaging Market
  • 9.4 Key Development Analysis
    • 9.4.1 Partnership/Strategic Agreement
    • 9.4.2 Acquisition
    • 9.4.3 Product Approval
    • 9.4.4 Expansion

10 Company Profiles

  • 10.1 General Electric Company
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Products/Services Offered
    • 10.1.4 Key Developments
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Strategies
  • 10.2 Siemens
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Products/Services Offered
    • 10.2.4 Key Developments
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Strategies
  • 10.3 Medtronic
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Products/Services Offered
    • 10.3.4 Key Developments
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Strategies
  • 10.4 Canon Medical Systems Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Products/Services Offered
    • 10.4.4 Key Developments
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Strategies
  • 10.5 Bracco Diagnostic, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Products/Services Offered
    • 10.5.4 Key Developments
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Strategies
  • 10.6 Koninklijke Philips NV
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Products/Services Offered
    • 10.6.4 Key Developments
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Strategies
  • 10.7 Neusoft Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Products/Services Offered
    • 10.7.4 Key Developments
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Strategies
  • 10.8 Lantheus Medical Imaging, Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Products/Services Offered
    • 10.8.4 Key Developments
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Strategies
  • 10.9 Shimadzu Corporation
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Products/Services Offered
    • 10.9.4 Key Developments
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Strategies
  • 10.1 Aetna
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Products/Services Offered
    • 10.10.4 Key Developments
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Strategies
  • 10.11 Perimed
    • 10.11.1 Company Overview
    • 10.11.2 Financial Overview
    • 10.11.3 Products/Services Offered
    • 10.11.4 Key Developments
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Strategies
  • 10.12 Advantis Medical Imaging
    • 10.12.1 Company Overview
    • 10.12.2 Financial Overview
    • 10.12.3 Products/Services Offered
    • 10.12.4 Key Developments
    • 10.12.5 SWOT Analysis
    • 10.12.6 Key Strategies

11 Appendix

  • 11.1 References
  • 11.2 Related Reports
Back to Top